Gastrointestinal tract viscosity enhancement

Gastrointestinal tract viscosity enhancement" does **not** refer to a specific molecule, receptor, enzyme, transporter, or other canonical therapeutic target. Instead, it describes the process of increasing the thickness (viscosity) of contents within the gastrointestinal tract—typically through dietary interventions such as adding soluble fibers or gel-forming agents like carboxymethylcellulose (CMC)[2]. Enhanced viscosity affects several physiological processes: - **Delays gastric emptying**, leading to increased satiety and altered postprandial motility[1][5]. - **Modifies nutrient absorption** by influencing diffusion rates and intestinal contraction patterns; shear-thinning non-Newtonian fluids can enhance uptake efficiency during segmentation contractions[3]. - **Alters gut structure and microbial environment**, potentially stimulating proliferation of certain bacteria like enterotoxigenic E. coli in animal models when high-viscosity diets are used long-term[2]. Because "gastrointestinal tract viscosity enhancement" is an intervention strategy or descriptive process—not a discrete molecular entity—it should not be classified as a therapeutic target per standard pharmacological definitions.

Not applicable; this is not a molecular target but rather a physical property or intervention strategy.